---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-292007"
form_type: "8-K"
ticker: null
cik: "0001797336"
company_name: "Ayala Pharmaceuticals, Inc."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:29:22.338541+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ayala receives Nasdaq delisting notice for MVPHS non-compliance; 180-day cure until May 2023

## Summary
- Nasdaq notified Ayala on Nov 18, 2022 of non-compliance with minimum $5M MVPHS requirement.
- Trading of AYLA common stock on Nasdaq Global Market is unaffected during the cure period.
- Ayala has until May 17, 2023 to regain compliance; MVPHS must close at $5M+ for 10 consecutive days.
- Possible remedies include transferring to Nasdaq Capital Market or appealing a delisting notice.

## SEC filing metadata
- accession: 0001193125-22-292007
- form_type: 8-K
- cik: 0001797336
- company_name: Ayala Pharmaceuticals, Inc.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1797336/000119312522292007/0001193125-22-292007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1797336/000119312522292007/d169360d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-292007
- JSON: https://secwatch.observer/filing/0001193125-22-292007.json
- Plain text: https://secwatch.observer/filing/0001193125-22-292007.txt

## Key facts
- Listing & Compliance Notices
  Ayala Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(1)(C)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5450(b)(1)(C)
  source text: November 18, 2022, Ayala Pharmaceuticals, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) of $5,000,000 required for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(1)(C) (the “MVPHS Requirement”). The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Global Market and the Company’s common stock will continue to trade under the s
  evidence_url: https://www.sec.gov/Archives/edgar/data/1797336/000119312522292007/0001193125-22-292007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.